[A new antiprogestational compound, mifepristone (RU-486)].
D000028:Abortion, Induced; D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D019049:Developed Countries; D004703:Endocrine System; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006727:Hormone Antagonists; D006728:Hormones; D007558:Italy; D008598:Menstruation; D015735:Mifepristone; D010060:Ovulation; D010827:Physiology
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D006727:Hormone Antagonists; D006728:Hormones; D015735:Mifepristone
Abortion, Drug Induced; Abortion, Induced; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Mode Of Action; Critique; Developed Countries; Endocrine System; Europe; Family Planning; Fertility Control, Postcoital; Fertility Control, Postconception; Hormone Antagonists; Hormones; Italy; Mediterranean Countries; Menstrual Regulation; Ovulation Suppression; Physiology; Ru-486; Southern Europe
Prospettive d'uso di un nuovo steroide ad azione antiprogesteronica: il Mifepristone (RU 486).